IAN T CLARK Insider Trading $DNA GENENTECH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for IAN T CLARK.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of IAN T CLARK. IAN T CLARK is EVP-COMMERCIAL in GENENTECH INC ($DNA) and EVP-COMMERCIAL OPERATIONS in GENENTECH INC ($DNA) and SVP-COMMERCIAL OPERATIONS in GENENTECH INC ($DNA) and Director in TerraVia Holdings, Inc. ($SZYM) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Kite Pharma, Inc. ($KITE) and Director in Guardant Health, Inc. ($GH) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Forty Seven, Inc. ($FTSV) and Director in AVROBIO, Inc. ($AVRO).
IAN T CLARK in GENENTECH INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of IAN T CLARK: EVP-COMMERCIAL OPERATIONS, SVP-COMMERCIAL OPERATIONS
Holdings: 0 shares
Latest Transaction: Mar 31 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of IAN T CLARK in GENENTECH INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, AVRO, CRVS, FTSV, DNA, GH, KITE, TVIA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | D | 85.83 | 125,000 | 10,728,750 | 0 | |
| Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | D | 79.55 | 125,000 | 9,943,750 | 0 | |
| Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | D | 79.17 | 135,000 | 10,687,950 | 0 | |
| Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | D | 53.23 | 5,938 | 316,080 | 0 | |
| Mar 31 2009 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | D | 95.00 | 963 | 91,485 | 0 | 963 to 0 (-100.00 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 100 | 5,323 | 5,938 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,600 | 85,168 | 6,038 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 600 | 31,938 | 7,638 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,400 | 74,522 | 8,238 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 2,700 | 143,721 | 9,638 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 2,380 | 126,687 | 12,338 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 3,028 | 161,180 | 14,718 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 200 | 10,646 | 17,746 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,509 | 80,324 | 17,946 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,600 | 85,168 | 19,455 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 7,700 | 409,871 | 21,055 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 2,700 | 143,721 | 28,755 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 2,700 | 143,721 | 31,455 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 2,600 | 138,398 | 34,155 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,600 | 67,280 | 3,019 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 983 | 41,335 | 4,619 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 5,917 | 248,810 | 5,602 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 900 | 37,845 | 11,519 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 113 | 4,752 | 12,419 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,500 | 63,075 | 12,532 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 100 | 4,205 | 14,032 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 3,500 | 147,175 | 14,132 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 100 | 4,205 | 17,632 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 800 | 33,640 | 17,732 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 600 | 25,230 | 18,532 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,100 | 46,255 | 19,132 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,100 | 46,255 | 20,232 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 100 | 4,205 | 21,332 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,694 | 71,233 | 21,432 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,205 | 50,670 | 23,126 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,400 | 58,870 | 24,331 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 300 | 12,615 | 25,731 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 619 | 26,029 | 26,031 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,900 | 79,895 | 26,650 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 200 | 8,410 | 28,550 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 700 | 29,435 | 28,750 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 400 | 16,820 | 29,450 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 4,800 | 201,840 | 29,850 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 2,100 | 88,305 | 34,650 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 100 | 4,205 | 36,750 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 2,200 | 92,510 | 36,850 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,100 | 46,255 | 39,050 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 100 | 4,205 | 40,150 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,000 | 42,050 | 40,250 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.47 | 100 | 8,047 | 668 | 768 to 668 (-13.02 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 100 | 5,323 | 768 | 668 to 768 (+14.97 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.43 | 1,600 | 128,688 | 668 | 2.3 K to 668 (-70.55 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,600 | 85,168 | 2,268 | 668 to 2.3 K (+239.52 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.42 | 600 | 48,252 | 668 | 1.3 K to 668 (-47.32 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 600 | 31,938 | 1,268 | 668 to 1.3 K (+89.82 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.41 | 1,400 | 112,574 | 668 | 2.1 K to 668 (-67.70 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,400 | 74,522 | 2,068 | 668 to 2.1 K (+209.58 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.40 | 2,700 | 217,080 | 668 | 3.4 K to 668 (-80.17 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 2,700 | 143,721 | 3,368 | 668 to 3.4 K (+404.19 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.38 | 2,380 | 191,304 | 668 | 3 K to 668 (-78.08 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 2,380 | 126,687 | 3,048 | 668 to 3 K (+356.29 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.37 | 3,028 | 243,360 | 668 | 3.7 K to 668 (-81.93 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 3,028 | 161,180 | 3,696 | 668 to 3.7 K (+453.29 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.36 | 200 | 16,072 | 668 | 868 to 668 (-23.04 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 200 | 10,646 | 868 | 668 to 868 (+29.94 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.35 | 1,509 | 121,248 | 668 | 2.2 K to 668 (-69.32 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,509 | 80,324 | 2,177 | 668 to 2.2 K (+225.90 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.34 | 1,600 | 128,544 | 668 | 2.3 K to 668 (-70.55 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,600 | 85,168 | 2,268 | 668 to 2.3 K (+239.52 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.33 | 7,700 | 618,541 | 668 | 8.4 K to 668 (-92.02 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 7,700 | 409,871 | 8,368 | 668 to 8.4 K (+1,152.69 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.32 | 2,700 | 216,864 | 668 | 3.4 K to 668 (-80.17 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 2,700 | 143,721 | 3,368 | 668 to 3.4 K (+404.19 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.31 | 2,700 | 216,837 | 668 | 3.4 K to 668 (-80.17 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 2,700 | 143,721 | 3,368 | 668 to 3.4 K (+404.19 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.30 | 2,600 | 208,780 | 668 | 3.3 K to 668 (-79.56 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 2,600 | 138,398 | 3,268 | 668 to 3.3 K (+389.22 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.28 | 1,400 | 112,392 | 668 | 2.1 K to 668 (-67.70 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,400 | 74,522 | 36,755 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 100 | 5,323 | 38,155 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 200 | 10,646 | 38,255 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,700 | 90,491 | 38,455 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 600 | 31,938 | 40,155 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,400 | 74,522 | 40,755 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,400 | 74,522 | 42,155 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,700 | 90,491 | 43,555 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 600 | 31,938 | 45,255 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,600 | 85,168 | 45,855 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 100 | 5,323 | 47,455 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 4,300 | 228,889 | 47,555 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 300 | 15,969 | 51,855 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,200 | 63,876 | 52,155 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,200 | 63,876 | 53,355 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 300 | 15,969 | 54,555 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 2,200 | 117,106 | 54,855 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 400 | 21,292 | 57,055 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 3,100 | 165,013 | 57,455 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 2,505 | 133,341 | 60,555 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 800 | 42,584 | 63,060 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,600 | 85,168 | 63,860 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 100 | 5,323 | 65,460 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 1,600 | 85,168 | 65,560 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 51 | 2,715 | 67,160 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 53.23 | 81 | 4,312 | 67,211 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 819 | 34,439 | 0 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 500 | 21,025 | 819 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 100 | 4,205 | 1,319 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Option Exercise | M | 42.05 | 1,600 | 67,280 | 1,419 | |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 300 | 15,969 | 968 | 668 to 968 (+44.91 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.08 | 2,200 | 176,176 | 668 | 2.9 K to 668 (-76.71 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 2,200 | 117,106 | 2,868 | 668 to 2.9 K (+329.34 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.05 | 400 | 32,020 | 668 | 1.1 K to 668 (-37.45 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 400 | 21,292 | 1,068 | 668 to 1.1 K (+59.88 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.04 | 3,100 | 248,124 | 668 | 3.8 K to 668 (-82.27 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 3,100 | 165,013 | 3,768 | 668 to 3.8 K (+464.07 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.03 | 2,505 | 200,475 | 668 | 3.2 K to 668 (-78.95 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 2,505 | 133,341 | 3,173 | 668 to 3.2 K (+375.00 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.02 | 800 | 64,016 | 668 | 1.5 K to 668 (-54.50 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 800 | 42,584 | 1,468 | 668 to 1.5 K (+119.76 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.01 | 1,600 | 128,016 | 668 | 2.3 K to 668 (-70.55 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,600 | 85,168 | 2,268 | 668 to 2.3 K (+239.52 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.99 | 100 | 7,999 | 668 | 768 to 668 (-13.02 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 100 | 5,323 | 768 | 668 to 768 (+14.97 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.98 | 1,600 | 127,968 | 668 | 2.3 K to 668 (-70.55 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,600 | 85,168 | 2,268 | 668 to 2.3 K (+239.52 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.94 | 51 | 4,077 | 668 | 719 to 668 (-7.09 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 51 | 2,715 | 719 | 668 to 719 (+7.63 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.93 | 81 | 6,474 | 668 | 749 to 668 (-10.81 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 81 | 4,312 | 749 | 668 to 749 (+12.13 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.93 | 819 | 65,463 | 668 | 1.5 K to 668 (-55.08 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 42.05 | 819 | 34,439 | 1,487 | 668 to 1.5 K (+122.60 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.92 | 500 | 39,960 | 668 | 1.2 K to 668 (-42.81 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 42.05 | 500 | 21,025 | 1,168 | 668 to 1.2 K (+74.85 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.91 | 100 | 7,991 | 668 | 768 to 668 (-13.02 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 42.05 | 100 | 4,205 | 768 | 668 to 768 (+14.97 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.90 | 1,600 | 127,840 | 668 | 2.3 K to 668 (-70.55 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 42.05 | 1,600 | 67,280 | 2,268 | 668 to 2.3 K (+239.52 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 79.89 | 1,600 | 127,824 | 668 | 2.3 K to 668 (-70.55 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,400 | 74,522 | 2,068 | 668 to 2.1 K (+209.58 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.26 | 100 | 8,026 | 668 | 768 to 668 (-13.02 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 100 | 5,323 | 768 | 668 to 768 (+14.97 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.25 | 200 | 16,050 | 668 | 868 to 668 (-23.04 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 200 | 10,646 | 868 | 668 to 868 (+29.94 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.24 | 1,700 | 136,408 | 668 | 2.4 K to 668 (-71.79 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,700 | 90,491 | 2,368 | 668 to 2.4 K (+254.49 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.23 | 600 | 48,138 | 668 | 1.3 K to 668 (-47.32 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 600 | 31,938 | 1,268 | 668 to 1.3 K (+89.82 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.21 | 1,400 | 112,294 | 668 | 2.1 K to 668 (-67.70 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Buy | M | 53.23 | 1,400 | 74,522 | 2,068 | 668 to 2.1 K (+209.58 %) |
| Jul 18 2008 | DNA | GENENTECH INC | CLARK IAN T | EVP-COMMERCIAL | Sell | S | 80.20 | 1,400 | 112,280 | 668 | 2.1 K to 668 (-67.70 %) |